A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : NRTIs

Search Conditions:
Search Keyword : NRTIs
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: NRTIs
Appearance Frequency: 1103 time(s)
Long forms: 15

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
nucleoside reverse transcriptase inhibitors
(1029 times)
Acquired Immunodeficiency Syndrome
(258 times)
NNRTIs (254 times)
PIs (181 times)
ART (157 times)
1995 Knocking out human immunodeficiency virus through non-nucleoside reverse transcriptase inhibitors used as single agents or in combinations: a paradigm for the cure of AIDS?
nucleoside RT inhibitors
(48 times)
Drug Therapy
(12 times)
RT (41 times)
NNRTIs (22 times)
HIV-1 (13 times)
Val or Ile and Val-75-->Leu or Ile) HIV-1 mutants. -->1996 Selective pressure of a quinoxaline nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on HIV-1 replication results in the emergence of nucleoside RT-inhibitor-specific (RT Leu-74-->Val or Ile and Val-75-->Leu or Ile) HIV-1 mutants.
nucleoside analog RT inhibitors
(6 times)
Anti-Bacterial Agents
(2 times)
RT (6 times)
HIV-1 (3 times)
NcRTIs (2 times)
2000 Biochemical mechanisms involved in overcoming HIV resistance to nucleoside inhibitors of reverse transcriptase.
nucleoside RTIs
(5 times)
Biology
(2 times)
NNRTIs (3 times)
RTIs (3 times)
NNRTI (2 times)
2000 Efavirenz is a potent nonnucleoside reverse transcriptase inhibitor of HIV type 1 replication in microglia in vitro.
nucleoside analogues inhibitors of the viral reverse transcriptase
(3 times)
Medicine
(1 time)
PIs (3 times)
NNRTIs (1 time)
2004 Antiviral profile of HIV inhibitors in macrophages: implications for therapy.
nucleoside reverse transcriptase
(3 times)
Acquired Immunodeficiency Syndrome
(2 times)
ABC (1 time)
CVR (1 time)
HDL (1 time)
2012 Differences in lipid measurements by antiretroviral regimen exposure in cohorts from Asia and australia.
dual-nucleoside reverse transcriptase inhibitor backbones
(1 time)
Microbiology
(1 time)
NNRTIs (1 time)
PIs (1 time)
2005 Sequencing antiretroviral drugs for long-lasting suppression of HIV replication.
genotypic resistance to nucleoside analogues
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
ARMs (1 time)
2008 Prevalence of genotypic resistance to nucleoside analogues, nonnucleoside analogues, and protease inhibitors in HIV-infected persons in Athens, Greece.
nighttime radiation temperature inversions
(1 time)
Environmental Health
(1 time)
STIs (1 time)
WPEs (1 time)
2011 Air pollution episodes associated with East Asian winter monsoons.
10  NNRTIs, which are the main support to the backbone
(1 time)
Medicine
(1 time)
ART (1 time)
NNRTI (1 time)
NRTI (1 time)
2019 Genetic diversity and antiretroviral resistance-associated mutation profile of treated and naive HIV-1 infected patients from the Northwest and Southwest regions of Cameroon.
11  non-nucleotide analogues acting as reverse transcriptase inhibitors
(1 time)
Science
(1 time)
PI (1 time)
2004 Human immunodeficiency virus type-1 accessory protein Vpr: a causative agent of the AIDS-related insulin resistance/lipodystrophy syndrome?
12  nucleoside analogue RTIs
(1 time)
Virology
(1 time)
ddI (1 time)
ETV (1 time)
HERV-K (1 time)
2017 Susceptibility of Human Endogenous Retrovirus Type K to Reverse Transcriptase Inhibitors.
13  nucleoside antiretroviral agents
(1 time)
Communicable Diseases
(1 time)
SQV-SGC (1 time)
2001 Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infection.
14  nucleoside inhibitors of the reverse transcriptase
(1 time)
Medicine
(1 time)
HIV (1 time)
NNRTI (1 time)
1999 [Nevirapine (Viramune): a new HIV inhibitor].
15  significant resistance to both nucleoside
(1 time)
Cell Biology
(1 time)
CS (1 time)
EFdA (1 time)
NNRTIs (1 time)
2012 Effect of translocation defective reverse transcriptase inhibitors on the activity of N348I, a connection subdomain drug resistant HIV-1 reverse transcriptase mutant.